1. Home
  2. ICU vs EVGN Comparison

ICU vs EVGN Comparison

Compare ICU & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$4.37

Market Cap

9.1M

Sector

Health Care

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.81

Market Cap

9.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICU
EVGN
Founded
2018
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
9.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ICU
EVGN
Price
$4.37
$0.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
118.5K
44.1K
Earning Date
05-14-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$53.00
N/A
Revenue Next Year
$50.00
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.72
52 Week High
$4.93
$2.42

Technical Indicators

Market Signals
Indicator
ICU
EVGN
Relative Strength Index (RSI) 60.51 40.06
Support Level $2.26 $0.73
Resistance Level $4.89 $1.23
Average True Range (ATR) 0.41 0.06
MACD -0.05 -0.00
Stochastic Oscillator 66.67 10.66

Price Performance

Historical Comparison
ICU
EVGN

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: